期刊文献+

抗人前列腺干细胞抗原单克隆抗体的制备及筛选 被引量:1

Preparation and selection of monoclonal antibodies against human prostate stem cell antigen
原文传递
导出
摘要 目的获得能够结合细胞表面前列腺干细胞抗原(prostate stem cell antigen,PSCA)的抗人PSCA单克隆抗体。方法以重组人PSCA蛋白为免疫原,通过杂交瘤技术制备抗人PSCA单克隆抗体,并进行ELISA、Western印迹、流式细胞术等实验筛选。结果获得6株抗人PSCA单克隆抗体,经过筛选最终得到3株能够结合细胞表面PSCA的单克隆抗体。结论获得具有结合细胞表面PSCA活性的单克隆抗体,为进一步研究和应用奠定了基础。 Objective To prepare and select monoclonal antibodies(mAb) against human prostate stem cell antigens(PSCA) in cells.Methods BALB/c mice were immunized with recombinant human PSCA.Anti-PSCA mAbs were obtained by hybridoma technique,tested by ELISA,Western blotting and flow cytometry.Results Six strains of anti-PSCA mAbs were acquired,three of which proved to be able to bind PSCA in cells after all tests.Conclusion Acquisition of anti-PSCA mAbs able to bind PSCA on the cell surface will facilitate further studies and applications.
出处 《军事医学》 CAS CSCD 北大核心 2013年第4期259-262,共4页 Military Medical Sciences
基金 国家自然科学基金资助项目(81172980)
关键词 前列腺肿瘤 肿瘤干细胞 抗体 单克隆 prostatic neoplasms neoplastic stem cells antibodies,monoclonal
  • 相关文献

参考文献12

  • 1Reiter RE, Gu Z,Watabe T, et al. Prostate stem cell antigen: acell surface marker overexpressed in prostate cancer [ J ]. ProcNatl Acad Sci USA, 1998,95(4) : 1735 -1740.
  • 2Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen(PSCA) expression increases with high Gleason score, advancedstage and bone metastasis in prostate cancer [ J ]. Oncogene,2000,19(10) : 1288 - 1296.
  • 3Dannull J, Diener PA, Prikler L, et al. Prostate stem cell anti-gen is a promising candidate for immunotherapy of advanced pros-tate cancer[ J]. Cancer Res, 2000,60( 19) : 5522 -5528.
  • 4Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell anti-gen as therapy target ; tissue expression and in vivo efficacy of animmunoconjugate[ J]. Cancer Res, 2002,62(9) : 2546 -2553.
  • 5Leyton JV, Olafsen T, Lepin EJ, et al. Humanized radioiodina-ted minibody for imaging of prostate stem cell antigen-expressingtumors[ J]. Clin Cancer Res,2008,14(22) : 7488 -7496.
  • 6Zhang X,Yu C,Zhao J,et al. Vaccination with a DNA vaccinebased on human PSCA and HSP70 adjuvant enhances the anti-gen-specific CD8+ T-cell response and inhibits the PSCA+tumors growth in mice [ J ] ‘ J Gene Med, 2007 ,9(8) ; 715 -726.
  • 7Han KR, Seligson DB, Liu X,et al. Prostate stem cell antigenexpression is associated with Gleason score,seminal vesicle inva-sion and capsular invasion in prostate cancer[ J]. J Urol, 2004,171(3) : 1117-1121.
  • 8Zhao Z, Shen W. Prostate stem cell antigen (PSCA) expressionin human prostate cancer tissues and its potential role in prostatecarcinogenesis and progression of prostate cancer [ J ]. World JSurg Oncol, 2004,2: 13.
  • 9Lam JS, Yamashiro J, Shintaku IP, et al. Prostate stem cell an-tigen is overexpressed in prostate cancer metastases [ J ]. ClinCancer Res, 2005,11(7) : 2591 -2596.
  • 10Larkin SE, Holmes S, Cree IA, et al. Identification of markersof prostate cancer progression using candidate gene expression[J]. BrJ Cancer, 2012,106(1): 157 -165.

同被引文献13

  • 1Reiter R E, Gu Z, Watabe T, et al. Prostate stem cell anti-gen: a cell surface marker overexpressed in prostate cancer[J]. Proc Natl Acad Sci USA, 1998,95(4):1735-1740.
  • 2Dannull J, Diener P A, Prikler L,et al. Prostate stem cell an-tigen is a promising candidate for immunotherapy of advancedprostate cancer[J]. Cancer Res, 2000,60(19):5522-5528.
  • 3Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell anti-gen(PSCA) expression increases with high gleason score, ad-vanced stage and bone metastasis in prostate cancer[J]. Onco-gene, 2000,19(10):1288-1296.
  • 4Ruberti F, Cattaneo A, Bradbury A. The use of the RACEmethod to clone hybridoma cDNA when V region primers fail[J]. J Immunol Metho, 1994,173(1):33-39.
  • 5Bradbury A. Cloning hybridoma cDNA by RACE[M]//Konter-man R, Stefan D,eds. Antibody Engineering (Vol 1). BerlinHeidelberg: Springer-Verlag, 2010:15-20.
  • 6Larkin S E, Holmes S, Cree I A, et al. Identification of mark-ers of prostate cancer progression using candidate gene expres-sion[J]. Br J Cancer, 2012,106(1):157-165.
  • 7Leyton J V,Olafsen T, Lepin E J, et al. Humanized radioio-dinated minibody for imaging of prostate stem cell antigen-ex-pressing tumors[J]. Clin Cancer Res, 2008,14(22):7488-7496.
  • 8Zhang X, Yu C, Zhao J, et al. Vaccination with a DNA vac-cine based on human PSCA and HSP70 adjuvant enhancesthe antigen-specific CD8 * T-cell response and inhibits thePSCA* tumors growth in mice[J]. J Gene Med, 2007,9(8):715-726.
  • 9Ross S, Spencer S D, Holcomb I, et al. Prostate stem cell an- tigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate[J]. Cancer Res, 2002,62(9):2546-2553.
  • 10Saffran D C, Raitano A B, Hubert R S, et al. Anti-PSCAmAbs inhibit tumor growth and metastasis formation and pro-long the survival of mice bearing human prostate cancer xeno-grafts[J]. Proc Natl Acad Sci USA, 2001,98(5):2658-2663.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部